Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chiesi Buys Denmark’s Zymenex For Phase III Enzyme Replacement Therapy

Aug 27 2013

• By John Davis

Related Content

Zealand Pharma Will Test European IPO Market

Nov 03 2010

Sanofi Claims Genzyme With $20.1 Billion Upfront And CVRs

Feb 21 2011

Abbott Adds To Renal Pipeline In Deal With Action Pharma

May 03 2012

uniQure Grants Chiesi Select Commercial Rights For The EU’s First Approved Gene Therapy Glybera And Hemo B Gene Therapy

Jul 10 2013

Related Companies

Chiesi Farmaceutici S.p.A.

uniQure N.V.

Sanofi

Takeda Pharmaceutical Co. Ltd.

Cornerstone Pharmaceuticals, Inc.

Action Pharma A/S

Abbott

EvoNext Holdings SA

Zealand Pharma A/S

Additional Topics

Denmark Europe Italy Deals Research & Development BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window